Year: 2019
Type: review
Abstract: The pancreas controls metabolism through endocrine and exocrine functions. Pancreatic diseases comprise a spectrum of mild to life-threatening conditions, including acute and chronic pancreatitis, diabetes, and pancreatic cancer, which affect endocrine and exocrine pancreatic function and impose a substantial disease burden on individuals. Increasing experimental evidence demonstrates that the intestinal microbiota has an important impact on pancreatic function and diseases. This influence may be conferred by bacterial metabolites, such as short-chain fatty acids, or the modulation of immune responses. In turn, pancreatic factors, such as the excretion of antimicrobials, might have a substantial impact on the composition and functional properties of the gut microbiota. Here, we summarize experimental and clinical approaches used to untie the intricate pancreas-microbiota cross talk. Future advances will allow clinicians to manipulate the intestinal microbiota and guide patient management in pancreatic diseases.
Source: Annual Review of Nutrition
Institutions: Innsbruck Medical University, Universität Innsbruck
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
Funders: European Crohn's and Colitis Organisation, Austrian Science Fund, Bundesministerium für Wissenschaft, Forschung und Wirtschaft, Österreichische Forschungsförderungsgesellschaft, Bundesministerium für Verkehr, Innovation und Technologie, Standortagentur Tirol, Wirtschaftsagentur Wien, Österreichische Gesellschaft für Gastroenterologie und Hepatologie
OpenAlex ID: W2969314526
